Actagene was a San Diego based privately held biotechnology company founded in February 2013 that was developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing.
Current Team (1)Update
|May 20, 2013||Bloomberg - Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine - Bloomberg|
|May 20, 2013||Business Wire - Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine|
San Diego, California